Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.
about
COPD immunopathologyDysfunctional lung anatomy and small airways degeneration in COPD1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late RhinosinusitisCytokine inhibition in the treatment of COPD.Effect of Abnormal Savda Munziq, a Traditional Uighur Herbal Medicine, on Pulmonary Function and Aquaporins of COPD Rat Model with Abnormal Savda SyndromeEffects of scutellarin on MUC5AC mucin production induced by human neutrophil elastase or interleukin 13 on airway epithelial cellsCOPD: balancing oxidants and antioxidants.Mucin production during prenatal and postnatal murine lung development.Genetic determinants of chronic obstructive pulmonary disease in South Indian male smokers.The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic BronchitisCentral role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5' elementsA short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPDCigarette smoke induces MUC5AC protein expression through the activation of Sp1.Regulation of airway mucin gene expressionThe role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease.Airway mucus: From production to secretion.Increased human Ca²⁺-activated Cl⁻ channel 1 expression and mucus overproduction in airway epithelia of smokers and chronic obstructive pulmonary disease patients.Regulation of mucin genes in chronic inflammatory airway diseases.Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study.Treatment of airway mucus hypersecretion.The role of airway secretions in COPD--clinical applications.MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study.MUC5AC and inflammatory mediators associated with respiratory outcomes in the British 1946 birth cohortMacrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium.Elastase- and LPS-exposed mice display altered responses to rhinovirus infection.Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.The cytokine network in chronic obstructive pulmonary disease.Innate immunity in the respiratory epithelium.Cellular and molecular biology of airway mucins.Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.Targeting mucus hypersecretion: new therapeutic opportunities for COPD?NPS2143 Inhibits MUC5AC and Proinflammatory Mediators in Cigarette Smoke Extract (CSE)-Stimulated Human Airway Epithelial Cells.Chronic inflammatory airway diseases: the central role of the epithelium revisited.Scutellarin attenuates human-neutrophil-elastase-induced mucus production by inhibiting the PKC-ERK signaling pathway in vitro and in vivo.Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.Sputum microbiology predicts health status in COPD.Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injuryFungal colonization with Pneumocystis correlates to increasing chloride channel accessory 1 (hCLCA1) suggesting a pathway for up-regulation of airway mucus responses, in infant lungs.
P2860
Q26749575-DAB2BCFC-C6BE-4E51-B54B-5CED1F9F72E1Q27009233-ECE33C94-E5AC-4888-A3AA-4B9BCC1E363DQ28546761-AF255500-763E-4F3F-82E6-03D050B29804Q33568552-66C2F564-C124-44E7-A428-56D052E69DBEQ33786790-5A238C89-8021-40FA-83B5-07B186743A53Q35009859-65E862DD-9316-42F7-A4DF-A12E23025CAAQ35063488-BC03173A-5164-4AD7-BD38-6AB79A7DCB28Q35103876-C53428D1-D119-4881-8810-7D2230C43248Q35108447-62D326CA-4C7A-4A17-AA7B-EFCB60EB2834Q35941653-98D379CB-FCD5-4F76-A8D9-4F6FBD42FBACQ36013719-FAAF5D70-EFE3-4F5E-A48F-83C338FF5F2BQ36018968-A9CDC3B0-F867-4BC7-978C-D46A451F9D01Q36201853-C67920BA-25F9-4C68-86B2-DA9CA1205C98Q36216587-400946FA-5F51-425F-B383-467186BA6EF0Q36305334-F416164A-3D9E-477C-BC23-2837895AD722Q36369409-E113D39D-2C34-4B58-9CA3-533ECBE4404BQ36373267-3561AA1E-D210-41D5-8AAE-A23072AEE74AQ36385590-033616C4-2D09-4224-859E-ED9C4A81A970Q36407059-5E05AD74-4A94-40CE-A010-0383185812E5Q36438219-929EBB14-0DD3-46BE-8E81-126F9DEB47D2Q36674113-9F9B15C9-769D-4317-BDE2-AE3C4EBC1F25Q37098496-A0E23BA0-36B3-4102-85E3-4E653E2F89C5Q37150785-982E61AF-0857-4DBA-84F0-BFF87D9E4E5EQ37201906-816CED0B-0046-4776-8954-ACDB43DA0474Q37266356-0B7E331A-6D94-48E0-AC5A-6DEAB96E90BBQ37291605-3A0711CD-DDD5-4F75-9D3E-AC77417DFCA3Q37421259-62A75B61-BE6C-4F10-955B-75C94C8961EFQ37431918-9E1A3AC7-250F-4FCB-AB6F-6C496FF73D20Q37589389-9F0DB2EC-29D2-4B1E-850F-B97267DFCE86Q37844340-F456948C-F1AD-4626-B6F5-1A1CACF9E678Q38085109-D5F74029-61D7-4FEB-A25D-B8BE8B9871D5Q38111793-CB429453-4C96-4594-BE85-25D4CD3B99D6Q38217069-6AF36758-C6BE-4C93-B7BE-A99E7410FB89Q38730058-48CB35F7-5F38-44B3-A632-8853AB0B36F7Q38791607-750D291B-D3DD-4EAA-BE83-80C8FD0CF40DQ39443009-9F191FB9-A219-48F9-8E19-8F38A558F5ADQ39804008-26E2AD3D-9244-4EE0-A803-7E4C215BE4A2Q40448821-D09A1A8D-B624-4A74-A229-20AB60344D53Q41429523-FBD9182E-FC46-4046-B2FB-C1D1A454E09FQ41671944-05A98F98-76D6-4151-ACDB-3487EEA23931
P2860
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Mucin expression in peripheral ...... obstructive pulmonary disease.
@en
Mucin expression in peripheral ...... obstructive pulmonary disease.
@nl
type
label
Mucin expression in peripheral ...... obstructive pulmonary disease.
@en
Mucin expression in peripheral ...... obstructive pulmonary disease.
@nl
prefLabel
Mucin expression in peripheral ...... obstructive pulmonary disease.
@en
Mucin expression in peripheral ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1433
P1476
Mucin expression in peripheral ...... obstructive pulmonary disease.
@en
P2093
Caramori G
Carlstedt I
Casolari P
Cavallesco G
Di Gregorio C
Guzzinati I
P2860
P304
P356
10.1111/J.1365-2559.2004.01952.X
P577
2004-11-01T00:00:00Z